DAICEL-EVONIK, LTD. – Trademark Portfolio

Entity Type: 03

DAICEL-EVONIK, LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MENDEX and DAIAMID. The owner is based in Shinjuku-ku, Tokyo,.

2-3-1, Nishi-shinjuku

Shinjuku-ku, Tokyo, 163-0913 , JP

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DAICEL-EVONIK, LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

25
Clothing (2 filings)

Clothing, footwear, headgear

17
Rubber Goods (2 filings)

Unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica

Frequently Asked Questions

How many trademarks does DAICEL-EVONIK, LTD. have?

DAICEL-EVONIK, LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does DAICEL-EVONIK, LTD. file in?

DAICEL-EVONIK, LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 25 (Clothing), Class 17 (Rubber Goods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are DAICEL-EVONIK, LTD.'s most well-known trademarks?

DAICEL-EVONIK, LTD.'s registered trademark portfolio includes well-known marks such as MENDEX and DAIAMID. These are among 2 currently registered trademarks in the portfolio.

What is DAICEL-EVONIK, LTD.'s trademark registration success rate?

DAICEL-EVONIK, LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.